Baiyunshan (00874) announced 2024 results, net profit of about 2,835 billion yuan, a year-on-year decrease of 30.09%

According to the Zhitong Finance App, Baiyunshan (00874) announced 2024 results, with operating income of about 74.993 billion yuan, a year-on-year decrease of 0.69%; net profit attributable to the company's shareholders was about 2,835 billion yuan, a year-on-year decrease of 30.09%; deducted non-net profit of about 2,356 billion yuan, a year-on-year decrease of 35.18%; basic earnings per share were 1,744 yuan, and a cash dividend of 0.40 yuan per share was planned.

According to the announcement, the main reason for the year-on-year decline in performance is that during the reporting period, the operating performance of the Group's main business segments declined year-on-year due to factors such as insufficient effective demand, accelerated industry change, industry policy changes and fierce market competition; during the reporting period, according to the relevant provisions of the “Corporate Accounting Standards”, the company prepared RMB 386 million for the impairment of Yixintang Pharmaceutical's long-term equity investment, thereby reducing the total profit for the year.